Latest News and Press Releases

AVITA Medical will report first quarter 2024 financial results after the close on May 13, 2024, and host a webcast that day at 1:30 p.m. Pacific Time.

AVITA Medical updates expected Q1 2024 commercial revenue; reaffirms expectations for full-year 2024 revenue at lower end of previously provided guidance.

AVITA Medical submitted its response to FDA for additional information in connection to RECELL GO PMA supplement. Submission resumes substantive review.

AVITA Medical to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024, at 9:50 a.m. Eastern Time.

AVITA Medical to host investor webinar briefing on February 27, 2024, at 2:00 p.m. PST.

AVITA Medical reports fourth quarter and full-year 2023 financial results.

AVITA Medical to announce fourth quarter and full year 2023 financial results on February 22, 2024, at 1:30 p.m. Pacific Time.

AVITA Medical announced exclusive multi-year distribution agreement with Stedical Scientific, Inc. to commercialize PermeaDerm in the United States.

AVITA Medical announced preliminary unaudited financial highlights for the fourth quarter 2023, 2024 financial guidance, and full enrollment of TONE.

AVITA Medical to present at JP Morgan's Annual Healthcare Conference in San Francisco on Thursday, January 11, 2024.